ACTRN12610000740099Completed未知
Measurement of anti-inflammatory resolvins and protectins in healthy individuals taking omega-3 fatty acids in combination with aspirin or placebo.
Professor Trevor Mori0 sites20 target enrollmentStarted: September 6, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Prevention
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 20 Years to 70 Years (—)
- Sex
- All
Inclusion Criteria
- •Men aged 20-70 years, and post-menopausal women aged less than 70 years will be recruited from the general population by newspaper advertisements. Volunteers will be included if they do not meet any of the criteria for the metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP: ATPIII).
Exclusion Criteria
- •Smokers, history of cardiovascular or peripheral vascular disease, diabetes, renal disease, liver disease or taking anti-hypertensive agents, lipid lowering drugs, hormone replacement therapy (women only), > 2 standard alcoholic drinks for women and >3 standard alcoholic drinks for men per day, aspirin or non-steroidal anti-inflammatory drugs, omega-3 fatty acids or >2 fish meals per week.
Investigators
Similar Trials
Completed
Not Applicable
Comparison of blood levels of factors involved in resolving inflammation in individuals with features of the metabolic syndrome versus matched healthy controlsOverweight men and womenCardiovascular - Other cardiovascular diseasesDiet and Nutrition - ObesityACTRN12610000708055Professor Trevor Mori40
Not yet recruiting
Not Applicable
Micro determination of non-steroidal anti - inflammatory patches in dried blood spots using high performance liquid chromatography / tandem mass spectrometryJoint pain, muscle pain, osteoarthritis, rheumatoid arthritisJPRN-UMIN000041567Gifu University10
Completed
Not Applicable
Study on the evaluation of anti-inflammation and anti-pigmentation effect of the P2 lotion after UV irradiation.Healthy adultJPRN-UMIN000046159Otsuka Pharmaceutical Co., Ltd.24
Completed
Phase 3
Anti-inflammatory property of papaya extract in Periapical inflammatioCTRI/2022/04/042049Dr Nishitha Arun66
Recruiting
Phase 3
colchicine in heart failureIschemic and non-ischemic heart failure with reduced ejection fraction (less than 40%).Heart failureIRCT20240617062161N1Mashhad University of Medical Sciences64